8. The European CanCer Organisation (ECCO) (2012, March 20). Dense breasts can nearly double the risk of breast cancer recurrence. ScienceDaily. Retrieved October 27, 2012, from http://www.sciencedaily.com /releases/2012/03/120321094129.htm
9. Carney PA, Miglioretti, DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R: Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med, 138: 168-75, 2003.
10. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey C, Key CR, Linver MN: Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology, 209: 511-8, 1998.
11. Saftlas AF, Szklo M: Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev, 9: 146-74, 1987.
12. Oza AM, Boyd NF: Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev, 15: 196-208, 1993.
13. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ:Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 7: 1133-44, 1998.
14. El-Bastawissi AY, White E, Mandelson MT, Taplin H: Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control, 11: 955-63, 2000.
15. Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA: Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control, 17: 1281-90, 2006.
16. Warren R: Hormones and mammographic breast density. Maturitas, 49: 67-78, 2004.
17. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS: Estrogen-plus-progestin use and mammographic density in postmenopausal women: women’s health initiative randomized trial. J Natl Cancer Inst, 97: 1366-76, 2005.
18. Tamimi RM, Byrne C, Colditz GA, Hankinson SE: Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2007, 99:1178-1187.
19. Hong CC, Tang BK, Rao V, Agarwal S, Marin L, Tritchler D, Yaffe M, Boyd NF: Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. Breast Cancer Research 2004, 6(4):R338-51.
20. Brooks PJ, Zakhari S: Moderate Alcohol Consumption and Breast Cancer in Women: From Epidemiology to Mechanisms and Interventions. Alcohol Clin Exp Res 2012, Oct 16. doi: 10.1111/j.1530-0277.2012.01888.x. [Epub ahead of print]
21. Antonova L, Aronson K, Mueller C. Stress and breast cancer: from epidemiology to molecular biology. Breast Cancer Research 2011; 13(2): 208.
22. Marconett CN, Singhal AK, Sundar SN, Firestone GL: Indole-3-Carbinol disrupts Estrogen Receptor-alpha dependent expression of Insulin-like Growth Factor-1 Receptor and Insulin Receptor Substrate-1 and proliferation of human breast cancer cells. Mol Cell Endocrinol 2012 Nov 5;363(1-2):74-84.
23. Gavrilova N, Lindau ST: Salivary Sex Hormone Measurement in a National, Population-Based Study of Older Adults. J Gerontol B PsycholSci Soc Sci 2009 Nov; 64B(suppl_1): i94–i105.
